Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies

  • Ana Maria Giménez-Arnau
  • , Robert Szalewski
  • , Michihiro Hide
  • , Vipul Jain
  • , Abdallah Khemis
  • , Mark Lebwohl
  • , Martin Metz
  • , Giselle Mosnaim
  • , Michael Palumbo
  • , Ekin Şavk
  • , Gordon Sussman
  • , Irena Walecka-Herniczek
  • , Bin Yang
  • , Claire Field
  • , Sibylle Haemmerle
  • , Karine Lheritier
  • , Paula G.P. Machado
  • , El Djouher Martzloff
  • , Noriko Seko
  • , Pengpeng Wang
  • Artem Zharkov, Sarbjit Saini

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science